Rottenstein Law Group Marks Inefficacy of Vibration Treatment for Osteoporosis

The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with some regret a report that a “novel treatment known as whole-body vibration doesn’t appear to improve the bone health of postmenopausal women who are at high risk of developing osteoporosis.” New York, NY (PRWEB) November 21, 2011 According to a November 15 piece published by U.S. News and World Report, the treatment, “which involves standing on a motorized, vibrating platform in the hope of building bone mass… showed promise in animals. But researchers, who hoped those
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations